IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,998,000 | -38.1% | 271,534 | -6.7% | 0.00% | -25.0% |
| Q1 2022 | $4,847,000 | -14.0% | 291,119 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $5,639,000 | -22.6% | 295,415 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $7,285,000 | -6.6% | 295,415 | -1.5% | 0.01% | -16.7% |
| Q2 2021 | $7,801,000 | -21.9% | 299,820 | -5.0% | 0.01% | -25.0% |
| Q1 2021 | $9,994,000 | -35.6% | 315,678 | -5.7% | 0.01% | -33.3% |
| Q4 2020 | $15,529,000 | +49.8% | 334,685 | +6.3% | 0.01% | +33.3% |
| Q3 2020 | $10,365,000 | +25.0% | 314,862 | +4.2% | 0.01% | +12.5% |
| Q2 2020 | $8,294,000 | +6.2% | 302,145 | +15.8% | 0.01% | -11.1% |
| Q1 2020 | $7,813,000 | -9.9% | 260,984 | -16.7% | 0.01% | +12.5% |
| Q4 2019 | $8,672,000 | +56.5% | 313,284 | +2.9% | 0.01% | +33.3% |
| Q3 2019 | $5,542,000 | -3.4% | 304,523 | +30.1% | 0.01% | -14.3% |
| Q2 2019 | $5,740,000 | +127.2% | 234,100 | -11.9% | 0.01% | +133.3% |
| Q1 2019 | $2,526,000 | -0.4% | 265,600 | -7.3% | 0.00% | -25.0% |
| Q4 2018 | $2,535,000 | +128.6% | 286,440 | +190.7% | 0.00% | +300.0% |
| Q3 2018 | $1,109,000 | -17.9% | 98,540 | -6.5% | 0.00% | -50.0% |
| Q2 2018 | $1,350,000 | -20.0% | 105,440 | +5.6% | 0.00% | 0.0% |
| Q1 2018 | $1,687,000 | – | 99,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |